CELADON PHARMACEUTICALS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.5 GBX | -5.13% |
|
-9.76% | -19.57% |
| 05-14 | Headlam warns of loss; EnSilica predicts revenue rise | AN |
| 05-14 | Celadon Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELADON PHARMACEUTICALS PLC | Other Pharmaceuticals | -5.13% | -9.76% | -19.57% | -39.34% | - | 79.54M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CEL Stock
- Charts Celadon Pharmaceuticals Plc
- Comparison Chart
